Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 481

1.

Prediction of Hypoxia in Brain Tumors Using a Multivariate Model Built from MR Imaging and 18F-Fluorodeoxyglucose Accumulation Data.

Shimizu Y, Kudo K, Kameda H, Harada T, Fujima N, Toyonaga T, Tha KK, Shirato H.

Magn Reson Med Sci. 2019 Oct 15. doi: 10.2463/mrms.mp.2019-0049. [Epub ahead of print]

2.

Percutaneous insertion of hepatic fiducial true-spherical markers for real-time adaptive radiotherapy.

Morita R, Abo D, Sakuhara Y, Soyama T, Katoh N, Miyamoto N, Uchinami Y, Shimizu S, Shirato H, Kudo K.

Minim Invasive Ther Allied Technol. 2019 Sep 13:1-10. doi: 10.1080/13645706.2019.1663217. [Epub ahead of print]

PMID:
31516050
3.

Quantitative evaluation of image recognition performance of fiducial markers in real-time tumor-tracking radiation therapy.

Miyamoto N, Maeda K, Abo D, Morita R, Takao S, Matsuura T, Katoh N, Umegaki K, Shimizu S, Shirato H.

Phys Med. 2019 Sep;65:33-39. doi: 10.1016/j.ejmp.2019.08.004. Epub 2019 Aug 12.

PMID:
31430584
4.

Lambda-Carrageenan Enhances the Effects of Radiation Therapy in Cancer Treatment by Suppressing Cancer Cell Invasion and Metastasis through Racgap1 Inhibition.

Wu PH, Onodera Y, Recuenco FC, Giaccia AJ, Le QT, Shimizu S, Shirato H, Nam JM.

Cancers (Basel). 2019 Aug 16;11(8). pii: E1192. doi: 10.3390/cancers11081192.

5.

Impact of organ motion on volumetric and dosimetric parameters in stomach lymphomas treated with intensity-modulated radiotherapy.

Uchinami Y, Suzuki R, Katoh N, Taguchi H, Yasuda K, Miyamoto N, Ito YM, Shimizu S, Shirato H.

J Appl Clin Med Phys. 2019 Aug;20(8):78-86. doi: 10.1002/acm2.12681. Epub 2019 Aug 10.

6.

Particle therapy for prostate cancer: The past, present and future.

Ishikawa H, Tsuji H, Murayama S, Sugimoto M, Shinohara N, Maruyama S, Murakami M, Shirato H, Sakurai H.

Int J Urol. 2019 Oct;26(10):971-979. doi: 10.1111/iju.14041. Epub 2019 Jul 8. Review.

PMID:
31284326
7.

Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study.

Fujima N, Shimizu Y, Yoshida D, Kano S, Mizumachi T, Homma A, Yasuda K, Onimaru R, Sakai O, Kudo K, Shirato H.

Cancers (Basel). 2019 Jun 10;11(6). pii: E800. doi: 10.3390/cancers11060800.

8.

[A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].

Mizumachi T, Kano S, Homma A, Akazawa M, Hasegawa C, Shiroishi Y, Okamoto C, Kumagai S, Nishimura M, Takasaki H, Takeda H, Yasuda K, Minatogawa H, Dekura Y, Onimaru R, Shirato H, Fukuda S.

Gan To Kagaku Ryoho. 2019 Apr;46(4):685-689. Japanese.

PMID:
31164507
9.

Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.

Hashimoto T, Shimizu S, Takao S, Terasaka S, Iguchi A, Kobayashi H, Mori T, Yoshimura T, Matsuo Y, Tamura M, Matsuura T, Ito YM, Onimaru R, Shirato H.

J Radiat Res. 2019 Jul 1;60(4):527-537. doi: 10.1093/jrr/rrz022.

10.

Projection-domain scatter correction for cone beam computed tomography using a residual convolutional neural network.

Nomura Y, Xu Q, Shirato H, Shimizu S, Xing L.

Med Phys. 2019 Jul;46(7):3142-3155. doi: 10.1002/mp.13583. Epub 2019 Jun 5.

PMID:
31077390
11.

Validity of One-Day Physical Activity Recall for Estimating Total Energy Expenditure in Elderly Residents at Long-Term Care Facilities: CLinical EValuation of Energy Requirements Study (CLEVER Study).

Nishida Y, Nakae S, Yamada Y, Kondo E, Yamaguchi M, Shirato H, Hirano H, Sasaki S, Tanaka S, Katsukawa F.

J Nutr Sci Vitaminol (Tokyo). 2019;65(2):148-156. doi: 10.3177/jnsv.65.148.

12.

The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients.

Prayongrat A, Kobashi K, Ito YM, Katoh N, Tamura M, Dekura Y, Toramatsu C, Khorprasert C, Amornwichet N, Alisanant P, Shirato H, Shimizu S.

Radiother Oncol. 2019 Jun;135:100-106. doi: 10.1016/j.radonc.2019.03.003. Epub 2019 Mar 19.

13.

Regulatory approval review of transcatheter mitral valve repair - Difference in the indication between the USA and Japan.

Konishi A, Ho M, Ouchi T, Mitsutake Y, Shirato H.

J Cardiol. 2019 Jul;74(1):13-18. doi: 10.1016/j.jjcc.2019.03.013. Epub 2019 Apr 17. Review.

PMID:
31005388
14.

Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.

Kato F, Kudo K, Yamashita H, Baba M, Shimizu A, Oyama-Manabe N, Kinoshita R, Li R, Shirato H.

Breast Cancer. 2019 Sep;26(5):628-636. doi: 10.1007/s12282-019-00969-0. Epub 2019 Apr 1.

PMID:
30937834
15.

A novel range-verification method using ionoacoustic wave generated from spherical gold markers for particle-beam therapy: a simulation study.

Takayanagi T, Uesaka T, Kitaoka M, Unlu MB, Umegaki K, Shirato H, Xing L, Matsuura T.

Sci Rep. 2019 Mar 8;9(1):4011. doi: 10.1038/s41598-019-38889-w.

16.

The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies.

Fujima N, Homma A, Harada T, Shimizu Y, Tha KK, Kano S, Mizumachi T, Li R, Kudo K, Shirato H.

Cancer Imaging. 2019 Feb 4;19(1):5. doi: 10.1186/s40644-019-0193-9.

17.

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis.

Katoh N, Onishi H, Uchinami Y, Inoue T, Kuriyama K, Nishioka K, Shimizu S, Komiyama T, Miyamoto N, Shirato H.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809983. doi: 10.1177/1533033818809983.

18.

Semi-quantitative analysis of pre-treatment morphological and intratumoral characteristics using 18F-fluorodeoxyglucose positron-emission tomography as predictors of treatment outcome in nasal and paranasal squamous cell carcinoma.

Fujima N, Hirata K, Shiga T, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Quant Imaging Med Surg. 2018 Sep;8(8):788-795. doi: 10.21037/qims.2018.09.09.

19.

Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).

Onimaru R, Onishi H, Ogawa G, Hiraoka M, Ishikura S, Karasawa K, Matsuo Y, Kokubo M, Shioyama Y, Matsushita H, Ito Y, Shirato H.

Jpn J Clin Oncol. 2018 Dec 1;48(12):1076-1082. doi: 10.1093/jjco/hyy141.

20.

Integrating quantitative morphological and intratumoural textural characteristics in FDG-PET for the prediction of prognosis in pharynx squamous cell carcinoma patients.

Fujima N, Hirata K, Shiga T, Li R, Yasuda K, Onimaru R, Tsuchiya K, Kano S, Mizumachi T, Homma A, Kudo K, Shirato H.

Clin Radiol. 2018 Dec;73(12):1059.e1-1059.e8. doi: 10.1016/j.crad.2018.08.011. Epub 2018 Sep 21.

PMID:
30245069
21.

Assessment of Coronary Flow Velocity Reserve in the Left Main Trunk Using Phase-contrast MR Imaging at 3T: Comparison with 15O-labeled Water Positron Emission Tomography.

Kikuchi Y, Naya M, Oyama-Manabe N, Manabe O, Sugimori H, Kudo K, Kato F, Aikawa T, Tsutsui H, Tamaki N, Shirato H.

Magn Reson Med Sci. 2019 Apr 10;18(2):134-141. doi: 10.2463/mrms.mp.2018-0003. Epub 2018 Jul 26.

22.

Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational study.

Inoue T, Katoh N, Ito YM, Kimura T, Nagata Y, Kuriyama K, Onishi H, Yoshitake T, Shioyama Y, Iizuka Y, Inaba K, Konishi K, Kokubo M, Karasawa K, Kozuka T, Tanaka K, Sakakibara-Konishi J, Kinoshita I, Shirato H.

Lung Cancer. 2018 Aug;122:107-112. doi: 10.1016/j.lungcan.2018.05.025. Epub 2018 May 29.

23.

Arf6-driven cell invasion is intrinsically linked to TRAK1-mediated mitochondrial anterograde trafficking to avoid oxidative catastrophe.

Onodera Y, Nam JM, Horikawa M, Shirato H, Sabe H.

Nat Commun. 2018 Jul 11;9(1):2682. doi: 10.1038/s41467-018-05087-7.

24.

Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.

Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, Arakawa Y, Miyamoto S, Beppu T, Sugiyama K, Nakamura H, Nagane M, Nakasu Y, Hashimoto N, Terasaki M, Matsumura A, Ishikawa E, Wakabayashi T, Iwadate Y, Ohue S, Kobayashi H, Kinoshita M, Asano K, Mukasa A, Tanaka K, Asai A, Nakamura H, Abe T, Muragaki Y, Iwasaki K, Aoki T, Watanabe T, Sasaki H, Izumoto S, Mizoguchi M, Matsuo T, Takeshima H, Hayashi M, Jokura H, Mizowaki T, Shimizu E, Shirato H, Tago M, Katayama H, Fukuda H, Shibui S; Japan Clinical Oncology Group.

J Clin Oncol. 2018 Jun 20:JCO2018786186. doi: 10.1200/JCO.2018.78.6186. [Epub ahead of print]

PMID:
29924704
25.

Learning Curve for Transcatheter Aortic Valve Implantation Under a Controlled Introduction System - Initial Analysis of a Japanese Nationwide Registry.

Handa N, Kumamaru H, Torikai K, Kohsaka S, Takayama M, Kobayashi J, Ogawa H, Shirato H, Ishii K, Koike K, Yokoyama Y, Miyata H, Motomura N, Sawa Y; Japanese TAVR Registry Participants.

Circ J. 2018 Jun 25;82(7):1951-1958. doi: 10.1253/circj.CJ-18-0211. Epub 2018 May 22.

26.

An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.

Hirayama S, Matsuura T, Ueda H, Fujii Y, Fujii T, Takao S, Miyamoto N, Shimizu S, Fujimoto R, Umegaki K, Shirato H.

Med Phys. 2018 Jul;45(7):3404-3416. doi: 10.1002/mp.12991. Epub 2018 Jun 19.

PMID:
29788552
27.

Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan.

Mizumoto M, Murayama S, Akimoto T, Demizu Y, Fukushima T, Ishida Y, Oshiro Y, Numajiri H, Fuji H, Okumura T, Shirato H, Sakurai H.

Cancer Med. 2018 May;7(5):1870-1874. doi: 10.1002/cam4.1464. Epub 2018 Mar 31.

28.

First Approval of Improved Medical Device Conditional on Use-Result Survey in Japan - Regulatory Review of Polymer-Free Drug-Coated BioFreedom Coronary Stent.

Konishi A, Ho M, Shirai Y, Shirato H.

Circ J. 2018 May 25;82(6):1487-1490. doi: 10.1253/circj.CJ-17-1425. Epub 2018 Mar 21. Review.

29.

Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.

Kobashi K, Prayongrat A, Kimoto T, Toramatsu C, Dekura Y, Katoh N, Shimizu S, Ito YM, Shirato H.

J Radiat Res. 2018 Mar 1;59(suppl_1):i50-i57. doi: 10.1093/jrr/rry018.

30.

Present developments in reaching an international consensus for a model-based approach to particle beam therapy.

Prayongrat A, Umegaki K, van der Schaaf A, Koong AC, Lin SH, Whitaker T, McNutt T, Matsufuji N, Graves E, Mizuta M, Ogawa K, Date H, Moriwaki K, Ito YM, Kobashi K, Dekura Y, Shimizu S, Shirato H.

J Radiat Res. 2018 Mar 1;59(suppl_1):i72-i76. doi: 10.1093/jrr/rry008.

31.

Time has come for proton and carbon beam therapy.

Shirato H.

Int J Clin Oncol. 2018 Jun;23(3):421-422. doi: 10.1007/s10147-018-1263-x. Epub 2018 Mar 8. Review. No abstract available.

PMID:
29520524
32.

Asymptomatic Isolated Calf Deep Vein Thrombosis: Does It Worsen after Varicose Vein Surgery?

Horiguchi S, Ono H, Shirato H, Kawakami T, Yabuki S, Morita N, Shirasugi N.

Ann Vasc Dis. 2017 Dec 25;10(4):364-370. doi: 10.3400/avd.oa.17-00104.

33.

Evaluation of the use of various rat strains for immunogenic potency tests of Sabin-derived inactivated polio vaccines.

Someya Y, Ami Y, Takai-Todaka R, Fujimoto A, Haga K, Murakami K, Fujii Y, Shirato H, Oka T, Shimoike T, Katayama K, Wakita T.

Biologicals. 2018 Mar;52:12-17. doi: 10.1016/j.biologicals.2018.02.001. Epub 2018 Feb 21.

PMID:
29475730
34.

Toll-like receptor 3 signal augments radiation-induced tumor growth retardation in a murine model.

Yoshida S, Shime H, Takeda Y, Nam JM, Takashima K, Matsumoto M, Shirato H, Kasahara M, Seya T.

Cancer Sci. 2018 Apr;109(4):956-965. doi: 10.1111/cas.13543. Epub 2018 Mar 25.

35.

Long-term outcomes of proton therapy for prostate cancer in Japan: a multi-institutional survey of the Japanese Radiation Oncology Study Group.

Iwata H, Ishikawa H, Takagi M, Okimoto T, Murayama S, Akimoto T, Wada H, Arimura T, Sato Y, Araya M, Mizoe JE, Gosho M, Nakamura K, Shirato H, Sakurai H.

Cancer Med. 2018 Mar;7(3):677-689. doi: 10.1002/cam4.1350. Epub 2018 Feb 14.

36.

Selection of external beam radiotherapy approaches for precise and accurate cancer treatment.

Shirato H, Le QT, Kobashi K, Prayongrat A, Takao S, Shimizu S, Giaccia A, Xing L, Umegaki K.

J Radiat Res. 2018 Mar 1;59(suppl_1):i2-i10. doi: 10.1093/jrr/rrx092.

37.

Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system.

Nishioka K, Prayongrat A, Ono K, Onodera S, Hashimoto T, Katoh N, Inoue T, Kinoshita R, Yasuda K, Mori T, Onimaru R, Shirato H, Shimizu S.

J Radiat Res. 2018 Mar 1;59(suppl_1):i63-i71. doi: 10.1093/jrr/rrx083.

38.

Comparison of the average surviving fraction model with the integral biologically effective dose model for an optimal irradiation scheme.

Takagi R, Komiya Y, Sutherland KL, Shirato H, Date H, Mizuta M.

J Radiat Res. 2018 Mar 1;59(suppl_1):i32-i39. doi: 10.1093/jrr/rrx084.

39.

Improvement of the repeatability of parallel transmission at 7T using interleaved acquisition in the calibration scan.

Kameda H, Kudo K, Matsuda T, Harada T, Iwadate Y, Uwano I, Yamashita F, Yoshioka K, Sasaki M, Shirato H.

J Magn Reson Imaging. 2018 Jul;48(1):94-101. doi: 10.1002/jmri.25903. Epub 2017 Dec 4.

PMID:
29205623
40.

Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction.

Sakamoto K, Oyama-Manabe N, Manabe O, Aikawa T, Kikuchi Y, Sasai-Masuko H, Naya M, Kudo K, Kato F, Tamaki N, Shirato H.

Jpn J Radiol. 2018 Feb;36(2):103-112. doi: 10.1007/s11604-017-0700-5. Epub 2017 Nov 9.

PMID:
29119456
41.

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.

Nishikawa Y, Yasuda K, Okamoto S, Ito YM, Onimaru R, Shiga T, Tsuchiya K, Watanabe S, Takeuchi W, Kuge Y, Peng H, Tamaki N, Shirato H.

Radiat Oncol. 2017 Sep 6;12(1):148. doi: 10.1186/s13014-017-0886-9.

42.

Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells.

Wu PH, Onodera Y, Ichikawa Y, Rankin EB, Giaccia AJ, Watanabe Y, Qian W, Hashimoto T, Shirato H, Nam JM.

Int J Nanomedicine. 2017 Jul 14;12:5069-5085. doi: 10.2147/IJN.S137833. eCollection 2017.

43.

Noninvasive electrical conductivity measurement by MRI: a test of its validity and the electrical conductivity characteristics of glioma.

Tha KK, Katscher U, Yamaguchi S, Stehning C, Terasaka S, Fujima N, Kudo K, Kazumata K, Yamamoto T, Van Cauteren M, Shirato H.

Eur Radiol. 2018 Jan;28(1):348-355. doi: 10.1007/s00330-017-4942-5. Epub 2017 Jul 11.

44.

Residual tumour detection in post-treatment granulation tissue by using advanced diffusion models in head and neck squamous cell carcinoma patients.

Fujima N, Yoshida D, Sakashita T, Homma A, Kudo K, Shirato H.

Eur J Radiol. 2017 May;90:14-19. doi: 10.1016/j.ejrad.2017.02.025. Epub 2017 Feb 20.

45.

Simple modification of arm position improves B1+ and signal homogeneity in the thoracolumbar spine at 3T.

Ishizaka K, Kudo K, Harada K, Shirai T, Fujiwara T, Aoike S, Takamori S, Shirato H.

J Magn Reson Imaging. 2018 Jan;47(1):123-130. doi: 10.1002/jmri.25767. Epub 2017 May 26.

PMID:
28556386
46.

Utility of a Hybrid IVIM-DKI Model to Predict the Development of Distant Metastasis in Head and Neck Squamous Cell Carcinoma Patients.

Fujima N, Sakashita T, Homma A, Yoshida D, Kudo K, Shirato H.

Magn Reson Med Sci. 2018 Jan 10;17(1):21-27. doi: 10.2463/mrms.mp.2016-0136. Epub 2017 May 18.

47.

A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate.

Fujii Y, Matsuura T, Takao S, Matsuzaki Y, Fujii T, Miyamoto N, Umegaki K, Nishioka K, Shimizu S, Shirato H.

J Radiat Res. 2017 Jul 1;58(4):591-597. doi: 10.1093/jrr/rrx020.

48.

Non-invasive prediction of the tumor growth rate using advanced diffusion models in head and neck squamous cell carcinoma patients.

Fujima N, Sakashita T, Homma A, Harada T, Shimizu Y, Tha KK, Kudo K, Shirato H.

Oncotarget. 2017 May 16;8(20):33631-33643. doi: 10.18632/oncotarget.16851.

49.

Educational outcomes of a medical physicist program over the past 10 years in Japan.

Kadoya N, Karasawa K, Sumida I, Arimura H, Kakinohana Y, Kabuki S, Monzen H, Nishio T, Shirato H, Yamada S.

J Radiat Res. 2017 Sep 1;58(5):669-674. doi: 10.1093/jrr/rrx016.

50.

Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.

Nishioka K, Shimizu S, Shinohara N, Ito YM, Abe T, Maruyama S, Katoh N, Kinoshita R, Hashimoto T, Miyamoto N, Onimaru R, Shirato H.

Radiat Oncol. 2017 Mar 1;12(1):44. doi: 10.1186/s13014-017-0778-z.

Supplemental Content

Loading ...
Support Center